AU Patent

AU2023320312A1 — Novel salts and crystals

Assigned to Intra Cellular Therapies Inc · Expires 2025-01-16 · 1y expired

What this patent protects

The disclosure provides new, stable, crystalline salt forms of lumateperone, together with methods of making and using them, and pharmaceutical compositions comprising them.

USPTO Abstract

The disclosure provides new, stable, crystalline salt forms of lumateperone, together with methods of making and using them, and pharmaceutical compositions comprising them.

Drugs covered by this patent

Patent Metadata

Patent number
AU2023320312A1
Jurisdiction
AU
Classification
Expires
2025-01-16
Drug substance claim
No
Drug product claim
No
Assignee
Intra Cellular Therapies Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.